InvoCare Limited is Again on an Acquisition Spree


InvoCare Limited (ASX: IVC) is in the business of providing Funeral, crematoria, cemetery and other related services in Australia, Singapore and New Zealand. On 19 September 2018, the company  made an announcement regarding acquisition of the assets and business of Harrison Funerals which is based in Ballarat, Victoria. Harrison is a growing funeral provider in Ballarat and it has been providing services since 2005.

It is anticipated that the acquisition will be completed by the end of the September 2018. Harrison Funerals conducts approximately 150 funeral services and generates revenue of approximately $ 1 million per year. The assets purchased by InvoCare includes prepaid contracts, freehold properties and fully equipped funeral home with mortuary and chapel. This acquisition has given opportunity to InvoCare for expansion in the regional markets. The company announced its acquisition of William Morrison Funeral on 14 August 2018. William Morrison Funeral business is based in Auckland, New Zealand. Morrisons is a   successful business which performs around 720 cremations, 950 funerals annually and generates revenue of around NZ$5.2 Million per year.

According to the Financial results for half year ended June 30, 2018, the company’s operating sales revenue was $225.7 million in H1 2018 which is an increase of 0.4% from the first half of last year’s operating sales which were $224.8 million. The operating EBITDA was $53.7 million which was 0.3% less than PCP. The statutory profit after tax was $20.8 million which decreased by 50% compared to last year. Net cash flow from operating activities decreased from $30.5m in H1 2017 to $12.8m in H1 2018 which is mainly due to non-recurring project related costs. The share price of the company increased by 0.249% as on 19 September 2018. IVC’s share traded at $12.100 at market capitalization of $1.33 billion as on 19 September 2018 (AEST 6:30 PM).

Dividend Stocks

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.


Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report